companydata.dkcompanydata.dk

Asahi Kasei Pharma Denmark A/S: Financial statements 2023

CVR: 40948074

Source: annual report 2023, Danish Business Authority

01/04/2022 – 31/03/2023

Asahi Kasei Pharma Denmark A/S (CVR 40948074) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -940,958 and a net result of DKK 18,232,738 compared with DKK 4,670,489 the year before. Equity in the 2023 report amounted to DKK 925,892,619. The solvency ratio was 99.5%.

Gross Profit
DKK -940,958
Profit/Loss
DKK 18,232,738
Equity
DKK 925,892,619
Total Assets
DKK 930,141,965
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--941K18.2M925.9M0
2022--1.2M4.7M907.7M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

About Asahi Kasei Pharma Denmark A/S

Asahi Kasei Pharma Denmark A/S is a Danish company of the type Aktieselskab based in Nordhavn, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named River Forest A/S. The management consists of Daisuke Matsuo. The board consists of Masaya Etoh (chair), Daisuke Matsuo and Kenro Yuzaki. The company is owned by Asahi Kasei Corporation. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK -793,488 and a net result of DKK 25,833,192 compared with DKK 26,072,771 the year before. Equity in the 2026 report amounted to DKK 1,003,291,531.

Source: annual report 2026, Danish Business Authority

Other financial years